135 related articles for article (PubMed ID: 14695788)
1. Rising plasma nociceptin level during development of HCC: a case report.
Horvath A; Folhoffer A; Lakatos PL; Halosz J; Illyes G; Schaff Z; Hantos MB; Tekes K; Szalay F
World J Gastroenterol; 2004 Jan; 10(1):152-4. PubMed ID: 14695788
[TBL] [Abstract][Full Text] [Related]
2. Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma.
Spadaro A; Ajello A; Luigiano C; Morace C; Resta ML; Berlinghieri G; Campo S; Scisca C; Alibrandi A; D'Arrigo G; Alessi N; Ferrau O; Freni MA
World J Gastroenterol; 2006 Aug; 12(29):4716-20. PubMed ID: 16937445
[TBL] [Abstract][Full Text] [Related]
3. Increased nociceptin/orphanin FQ plasma levels in hepatocellular carcinoma.
Szalay F; Hantos MB; Horvath A; Lakatos PL; Folhoffer A; Dunkel K; Hegedus D; Tekes K
World J Gastroenterol; 2004 Jan; 10(1):42-5. PubMed ID: 14695766
[TBL] [Abstract][Full Text] [Related]
4. Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinoma.
Zhang HJ; Yao DF; Yao M; Huang H; Wu W; Yan MJ; Yan XD; Chen J
World J Gastroenterol; 2012 Nov; 18(41):5897-904. PubMed ID: 23139605
[TBL] [Abstract][Full Text] [Related]
5. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular Carcinoma.
Jang ES; Jeong SH; Kim JW; Choi YS; Leissner P; Brechot C
PLoS One; 2016; 11(3):e0151069. PubMed ID: 26986465
[TBL] [Abstract][Full Text] [Related]
7. Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma.
Liu T; Yao M; Liu S; Wang L; Wang L; Hou J; Ma X; Jia J; Zhao J; Zhuang H; Lu F
Oncotarget; 2017 Mar; 8(10):16498-16506. PubMed ID: 28157705
[TBL] [Abstract][Full Text] [Related]
8. Serum metabolites may be useful markers to assess vascular invasion and identify normal alpha-fetoprotein in hepatocellular carcinoma undergoing liver resection: a pilot study.
Lee CW; Yu MC; Lin G; Chiu JC; Chiang MH; Sung CM; Hsieh YC; Kuo T; Lin CY; Tsai HI
World J Surg Oncol; 2020 Jun; 18(1):121. PubMed ID: 32493393
[TBL] [Abstract][Full Text] [Related]
9. A case of well-differentiated hepatocellular carcinoma arising in primary biliary cirrhosis.
Yano Y; Yoon S; Seo Y; Ninomiya T; Nagano H; Nakaji M; Hayashi Y; Kasuga M
Kobe J Med Sci; 2003; 49(1-2):39-43. PubMed ID: 12796567
[TBL] [Abstract][Full Text] [Related]
10. Serum transforming growth factor alpha level as a marker of hepatocellular carcinoma complicating cirrhosis.
Tomiya T; Fujiwara K
Cancer; 1996 Mar; 77(6):1056-60. PubMed ID: 8635123
[TBL] [Abstract][Full Text] [Related]
11. High plasma concentrations of endothelin-like immunoreactivities in patients with hepatocellular carcinoma.
Nakamuta M; Ohashi M; Tabata S; Tanabe Y; Goto K; Naruse M; Naruse K; Hiroshige K; Nawata H
Am J Gastroenterol; 1993 Feb; 88(2):248-52. PubMed ID: 8380950
[TBL] [Abstract][Full Text] [Related]
12. Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis.
Giannini EG; Marenco S; Borgonovo G; Savarino V; Farinati F; Del Poggio P; Rapaccini GL; Anna Di Nolfo M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
Hepatology; 2012 Oct; 56(4):1371-9. PubMed ID: 22535689
[TBL] [Abstract][Full Text] [Related]
13. The Expressions of CD44, CD90 and Alpha Fetoprotein Biomarkers in Indonesian Patients with Advanced Liver Disease: an Observational Study.
Mustika S; Wijaya H; Pratomo B
Acta Med Indones; 2019 Apr; 51(2):137-144. PubMed ID: 31383828
[TBL] [Abstract][Full Text] [Related]
14. Overlap syndrome of autoimmune hepatitis and primary biliary cholangitis complicated with atypical hepatocellular carcinoma: a case report.
Surdea-Blaga T; Cărăguț RL; Caraiani C; Spârchez Z; Al Hajjar N; Dumitrașcu DL
J Med Case Rep; 2023 Jul; 17(1):328. PubMed ID: 37488645
[TBL] [Abstract][Full Text] [Related]
15. Plasma proteasome level is a reliable early marker of malignant transformation of liver cirrhosis.
Henry L; Lavabre-Bertrand T; Vercambre L; Ramos J; Carillo S; Guiraud I; Pouderoux P; Bismuth M; Valats JC; Demattei C; Duny Y; Chaze I; Funakoshi N; Bureau JP; Daurès JP; Blanc P
Gut; 2009 Jun; 58(6):833-8. PubMed ID: 19201777
[TBL] [Abstract][Full Text] [Related]
16. Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases.
Shirai Y; Kawata S; Tamura S; Ito N; Tsushima H; Takaishi K; Kiso S; Matsuzawa Y
Cancer; 1994 May; 73(9):2275-9. PubMed ID: 7513247
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Osteopontin as a Biomarker in Hepatocellular Carcinomas in Egyptian Patients with Chronic HCV Cirrhosis.
Abdel-Hafiz SM; Hamdy HE; Khorshed FM; Aboushousha TS; Safwat G; Saber MA; Seleem M; Soliman AH
Asian Pac J Cancer Prev; 2018 Apr; 19(4):1021-1027. PubMed ID: 29693976
[TBL] [Abstract][Full Text] [Related]
18. An analysis of the UNOS liver transplant registry: high serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma.
Kemmer N; Neff G; Kaiser T; Zacharias V; Thomas M; Tevar A; Satwah S; Shukla R; Buell J
Liver Transpl; 2006 Oct; 12(10):1519-22. PubMed ID: 17004260
[TBL] [Abstract][Full Text] [Related]
19. Supervised learning reveals circulating biomarker levels diagnostic of hepatocellular carcinoma in a clinically relevant model of non-alcoholic steatohepatitis; An OAD to NASH.
Hwang A; Shi C; Zhu E; Naaz F; Zhou P; Rasheed Z; Liu M; Jung LS; Duan B; Li J; Jiang K; Paka L; Gadhiya SV; Dana D; Ali Q; Yamin MA; Goldberg ID; Narayan P
PLoS One; 2018; 13(6):e0198937. PubMed ID: 29944670
[TBL] [Abstract][Full Text] [Related]
20. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
